Diabetes Management Certificate

   
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This self-guided, online learning activity is intended for pharmacists who wish to build their knowledge and skills necessary to provide patient-centered diabetes care management.

Introduction to Diabetes Management
ACPE #: 0204-0000-23-812-H01-P

Learning Objectives:
• Apply the recommendations for strengths-based, person-centered language in diabetes.
• Recognize words and phrases that are unhelpful in diabetes.
• Identify professional resources for diabetes language.
• Differentiate treatment options for patients with various types of diabetes other than type 2.

Goals of Diabetes Management
ACPE #: 0204-0000-23-813-H01-P

Learning Objectives:
• Develop individualized glucose goals for different types of patient scenarios.
• Compare and contrast self-monitoring of blood glucose to continuous glucose monitors.
• Design a glucose monitoring plan for a given patient scenario.
• Describe the microvascular and macrovascular complications of diabetes.
• Apply current recommendations for the screening of chronic complications in patients with type 1 and type 2 diabetes.
• Apply current treatment goals and recommendations to prevent and/or slow the progression of chronic complications in patients with type 1 and type 2 diabetes.

Facilitating Behavior Change
ACPE #: 0204-0000-23-814-H01-P

Learning Objectives:
• Describe the importance of diabetes self-management education and support to improve outcomes.
• Utilize principles of motivational interviewing in a patient encounter.
• Discuss the impact of physical activity on glucose management including types of activity, safety concerns, and medication adjustments.
• Recommend physical activity using a strengths-based approach.
• Apply the current nutrition consensus statement on nutrition for adults with type 1, type 2, and pre-diabetes with considerations for weight management and disordered eating.
• Differentiate between evidence-based eating patterns and carbohydrate counting, including teaching resources for these options.
• Compare and contrast approaches to diabetes nutrition such as ketogenic, fasting / intermittent fasting, and personalized nutrition with gut microbiome.
• Apply appropriate person-centered nutrition approaches to people with diabetes and pre-diabetes.
• Discuss challenges to diabetes self-management including stress, sleep, support, mental health, diabetes distress/burnout, and social determinants of health.

Diabetes Treatment: Oral and Non-Insulin Injectables
ACPE #: 0204-0000-23-815-H01-P

Learning Objectives:
• Apply drug mechanism of action through a pathophysiologic treatment approach.
• Compare and contrast drug therapy efficacy and monitoring parameters to determine appropriate use through evidenced-base medicine.
• Discuss patient and provider perceived barriers to drug therapy.
• Recommend drug therapy for specific patient case scenarios.
• Apply drug mechanism of action through a pathophysiologic treatment approach.
• Compare and contrast drug therapy efficacy and monitoring parameters to determine appropriate use through evidenced-base medicine.
• Discuss patient and provider perceived barriers to drug therapy.
• Recommend drug therapy for specific patient case scenarios.
• Design shared decision discussions about drug therapy to reduce clinical inertia.

Diabetes Treatment with Insulin
ACPE #: 0204-0000-23-816-H01-P

Learning Objectives:
• Compare and contrast insulin types.
• Calculate insulin doses for a person with a new diagnosis of type 1 diabetes.
• Explain how to safely add insulin to non-insulin agents.
• Discuss the various types of insulin and distinguishing factors between types.
• Design an insulin regimen based on individual patient factors.
• Modify a treatment plan for a person needing intensification of insulin therapy.
• Adjust treatment plans using pattern management skills based on hypoglycemia, hyperglycemia, or other treatment considerations.

Diabetes Treatment for Cardiovascular Conditions
ACPE #: 0204-0000-23-817-H01-P

Learning Objectives:
• Interpret the historical significance behind the requirement for cardiovascular outcomes trials.
• Apply evidence from the cardiovascular outcomes trials for DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors to support therapeutic recommendations for people with type 2 diabetes and atherosclerotic cardiovascular disease.
• Discuss the onset, prognosis, and etiology of chronic heart failure in persons with type 2 diabetes.
• Describe clinical practice considerations for the management of persons with type 2 diabetes and chronic heart failure.
• State the proposed rationale for the nephroprotective effects of SGLT2 inhibitors.
• Apply evidence from the cardiovascular and kidney outcomes trials for SGLT2 inhibitors to support therapeutic recommendations for persons with type 2 diabetes and chronic kidney disease.
• Modify antihyperglycemic therapy according to current recommendations for kidney dosing adjustments.
• Apply evidence from the cardiovascular outcomes trials to support therapeutic recommendations for people with type 2 diabetes.
• Design a treatment plan to improve blood glucose management in people with type 2 diabetes, taking into account co-morbid conditions and patient specific factors.

Diabetes Treatment: Weight, Hypoglycemia, and Cost Considerations
ACPE #: 0204-0000-23-818-H01-P

Learning Objectives:
• Distinguish pathophysiological concepts related to obesity.
• Summarize current evidence-based recommendations for the treatment of obesity.
• Develop a treatment plan for a person with obesity and diabetes.
• Describe strategies and treatments currently available for the management of hypoglycemia.
• Differentiate between glucose-lowering medications based on their risk of contributing to hypoglycemia.
• Design an appropriate treatment and monitoring plan for a person with hypoglycemia unawareness.
• Apply recommendations for hypoglycemia prevention and treatment to a patient case scenario.
• Compare and contrast different cost savings programs for people with diabetes.
• Recommend a cost-saving strategy for a person having difficulty paying for diabetes medications.

Diabetes Technology
ACPE #: 0204-0000-23-819-H01-P

Learning Objectives:
• Compare and contrast continuous glucose monitoring devices.
• Design a treatment regimen based on continuous glucose monitoring data.
• Use the DATAA tool to engage in discussion with a person with diabetes about their glucose data.
• Describe how continuous glucose monitoring data is integrated with connected devices.
• Discuss critical teaching content before starting insulin pump therapy.
• Compare and contrast the currently available insulin pumps.
• Use insulin pump data to adjust treatment.
• Evaluate the quality of diabetes-related mobile applications using evidence-informed criteria.
• Differentiate between the various diabetes-related mobile applications available.
• Apply the utility of a mobile application’s characteristics and functionalities to a patient-specific scenario.

Pharmacotherapy Complications
ACPE #: 0204-0000-23-820-H01-P

Learning Objectives:
• Summarize current evidence-based recommendations for the management of macrovascular complications for persons with diabetes.
• Recommend a treatment plan for a person with diabetes and macrovascular complications.
• Summarize current evidence-based recommendations for the management of microvascular complications for persons with diabetes.
• Recommend a treatment plan for a person with diabetes and microvascular complications.
• Differentiate the pathophysiology behind diabetic ketoacidosis and hyperosmolar hyperglycemic state.
• Design an appropriate treatment plan for managing hyperglycemic crises.

Special Populations
ACPE #: 0204-0000-23-821-H01-P

Learning Objectives:
• Use current guidelines to guide therapy decisions in older adults with diabetes.
• Use patient-specific characteristics to individualize A1C and blood glucose goals.
• Compare the potential risks versus benefits of therapies for older adults.
• Evaluate medication regimens of older adults to determine candidacy for deprescribing.
• Design a treatment plan for pediatric patients that considers individualized glycemic targets.
• Differentiate common symptoms for children with new onset diabetes.
• Identify diagnostic criteria for diabetes in the pediatric population.
• Prioritize diabetes management strategies based on the child/adolescent’s age, development, home environment, and school setting.
• Design a treatment plan for pediatric patients that takes individualized glycemic targets into consideration.
• Recommend appropriate lifestyle interventions, glucose monitoring, and insulin therapy for children with diabetes.
• Compare and contrast available diabetes technology products.
• Apply conclusions of the 2021 TODAY trial to clinical practice.
• Recommend treatment plans for pediatric patients with type 2 diabetes that include lifestyle and pharmacologic interventions.
• Develop a plan to monitor for complications of diabetes in pediatric patients according to American Diabetes Association Standards of Care.
• Describe the diagnostic criteria for gestational diabetes.
• Discuss glucose targets for pregnancy.
• Design a treatment regimen for a person with gestational diabetes or pre-existing diabetes in pregnancy.
• Discuss glucose targets for pregnancy.
• Assess which diabetes-related medications should be stopped in pregnancy.
• Design a treatment regimen for a person with gestational diabetes or pre-existing diabetes in pregnancy.

Ambulatory Care Roles in Diabetes
ACPE #: 0204-0000-23-822-H01-P

Learning Objectives:
• Apply evidence-informed principles for successful integration within an interprofessional care team.
• Compare and contrast the various certifications available for pharmacists in diabetes care."
• Differentiate sustainable reimbursement opportunities for pharmacists providing diabetes services in various health care practices.
• Interpret the rules and regulations of billing codes available to pharmacists for diabetes services reimbursement.
• Differentiate population health and chronic care management approaches for persons with diabetes.
• Develop strategies to improve the health of a diabetes population.
• Interpret quality measure reports to establish target measures of population health initiatives.
• Recommend mHealth apps based on patient specific monitoring needs and technology desires for persons with diabetes.

Diabetes Management in the Hospital Setting
ACPE #: 0204-0000-23-823-H01-P

Learning Objectives:
• Compare various approaches to achieving good glycemic management in the hospital setting.
• Apply current standards of inpatient care to manage hospitalized patients with hyperglycemia or diabetes.
• Use effective strategies to safety optimize the glycemic management of hospitalized patients with diabetes and hyperglycemia.
• Interpret blood glucose data to improve glycemic management across the hospital.
• Prioritize the need to improve quality of care for hospitalized patients with diabetes through institutional policy and protocol development.
• Design hospital policies and protocols that align with recommendations from national organizations to optimize patient care outcomes.
• Describe the impact of diabetes management teams on the quality of care of hospitalized patients with diabetes.
• Design an institutional diabetes management team using current best practices as a framework.
• Recommend specific strategies to ensure safety and quality in inpatient glycemic management.
• Recommend insulin regimens for hospitalized patients with hyperglycemia based on patient-specific characteristics and current glycemic patterns.

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

•          No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

As defined by the Standards of Integrity and Independence definition of ineligible company. All relevant financial relationships have been mitigated prior to the CPE activity. 

This online activity consists of a combined total of 12 learning modules. Pharmacists are eligible to receive a total of 36 hours of continuing education credit by completing all 12 modules within this professional certificate. 

Participants must participate in the entire activity and complete the evaluation and all required components to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts to claim credit and view your statement of credit within 60 days of completing the activity.

Important Note – ACPE 60 Day Deadline: 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP profile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.